Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

The "Lists": What Do They Mean?

Author(s):  Voliva John

Issue:  Nov/Dec 2016 - Volume 20, Number 6
View All Articles in Issue

Page(s):  477-479

The
The
The

Download in electronic PDF format for $65

Abstract:  

Related Keywords: John Voliva, RPh, U.S. Food and Drug Administration, FDA, International Academy of Compounding Pharmacists, IACP, do not compound, positive list, negative list, demonstrably difficult list, Pharmacy Compounding Advisory Committee, PCAC, Federal Food, Drug, and Cosmetic Act, FD&C Act, Section 503A, pharmacy regulation

Related Categories: LEGAL, SUPPORT, QUALITY CONTROL, DISCONTINUED FORMULATIONS, UNITED STATES PHARMACOPEIA CONVENTIONS, INFORMATION RESOURCES

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
The "Lists": What Do They Mean?
Voliva John
Nov/Dec 2016
Pg. 477-479

U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List)
Nov/Dec 2016
Pg. 457-458

Basics of Compounding: The "Negative" List
Allen Loyd V
Jul/Aug 2015
Pg. 311-313

Basics of Compounding: The Revised "Not to Compound List"
Allen Loyd V Jr
Jan/Feb 2015
Pg. 57-58

The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter
Miller David G
May/Jun 2014
Pg. 208

The US FDA List of Drugs Not to Be Used in Compounded Medications for Humans (the "Negative List")
Allen Loyd V Jr
, Ashworth Lisa D
Jan/Feb 2005
Pg. 44-46

Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA
Cabaleiro Joe
Sep/Oct 2021
Pg. 358-362

Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A
Blankenship Cynthia E
Sep/Oct 2014
Pg. 379-380

U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs
Allen Loyd V Jr
Nov/Dec 2015
Pg. 487-488

U.S. Food and Drug Administration Inspections: Guide to a Successful Outcome for 503A Sterile Compounding Pharmacies
Yoch Doug
Mar/Apr 2017
Pg. 95-102

PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs
Allen Loyd V Jr
Sep/Oct 2017
Pg. 356

Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines
Allen Loyd V Jr
Jul/Aug 2016
Pg. 351

View Sample
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1
Allen Loyd V Jr
Sep/Oct 2015
Pg. 389-390

IACP's Continuing Support of Compounding Pharmacists: Letter to the FDA Concerning 503B Outsourcing Facilities
Miller David G
Mar/Apr 2014
Pg. 117-118

Legislative/Regulatory Update: From the International Academy of Compounding Pharmacists: Appropriations
McCrory Gary
Mar/Apr 2016
Pg. 95-96

How to Develop and Maintain a Hazardous Drug List
Dillon L Rad
May/Jun 2019
Pg. 182-186

International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Good and Drug Administration's Misguided Veterminary Guidance
Miller David G
Nov/Dec 2015
Pg. 449-450

The International Academy of Compounding Pharmacists Comments to the Draft Memorandum of Understanding
Miller David G
Sep/Oct 2015
Pg. 375

U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances
Miller David G
Jul/Aug 2015
Pg. 303-305

The International Academy of Compounding Pharmacists Introduces a New President
Rice Baylor
Mar/Apr 2017
Pg. 116-117